Product NDC: | 0409-4054 |
Proprietary Name: | Clindamycin |
Non Proprietary Name: | CLINDAMYCIN PHOSPHATE |
Active Ingredient(s): | 150 mg/mL & nbsp; CLINDAMYCIN PHOSPHATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-4054 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062801 |
Marketing Category: | ANDA |
Start Marketing Date: | 19870724 |
Package NDC: | 0409-4054-03 |
Package Description: | 25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-4054-03) > 4 mL in 1 VIAL, PATENT DELIVERY SYSTEM |
NDC Code | 0409-4054-03 |
Proprietary Name | Clindamycin |
Package Description | 25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-4054-03) > 4 mL in 1 VIAL, PATENT DELIVERY SYSTEM |
Product NDC | 0409-4054 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CLINDAMYCIN PHOSPHATE |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 19870724 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 150 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |